Brief: InDex Pharmaceuticals To Proceed With Reverse Merger
April 8 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* PROVIDES A COMPANY UPDATE
* DECIDED TO PROCEED WITH RECOMMENDED REVERSE MERGER
* DECISION ON HOW TO PROCEED WILL BE SUBJECT TO SHAREHOLDER
APPROVAL AT A LATER EXTRAORDINARY GENERAL MEETING
* EXPECTS TO BE ABLE TO PROVIDE MORE DETAILS BEFORE ANNUAL
GENERAL
MEETING ON MAY 7, 2024
Source text for Eikon: ID:nWkr9CS8M
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen